[go: up one dir, main page]

GB2052981B - Penicillanic acid derivatives as -lactamose inhibitors - Google Patents

Penicillanic acid derivatives as -lactamose inhibitors

Info

Publication number
GB2052981B
GB2052981B GB8020953A GB8020953A GB2052981B GB 2052981 B GB2052981 B GB 2052981B GB 8020953 A GB8020953 A GB 8020953A GB 8020953 A GB8020953 A GB 8020953A GB 2052981 B GB2052981 B GB 2052981B
Authority
GB
United Kingdom
Prior art keywords
lactamose
inhibitors
acid derivatives
penicillanic acid
penicillanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8020953A
Other versions
GB2052981A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB8020953A priority Critical patent/GB2052981B/en
Publication of GB2052981A publication Critical patent/GB2052981A/en
Application granted granted Critical
Publication of GB2052981B publication Critical patent/GB2052981B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8020953A 1979-07-02 1980-06-26 Penicillanic acid derivatives as -lactamose inhibitors Expired GB2052981B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8020953A GB2052981B (en) 1979-07-02 1980-06-26 Penicillanic acid derivatives as -lactamose inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7922885 1979-07-02
GB8020953A GB2052981B (en) 1979-07-02 1980-06-26 Penicillanic acid derivatives as -lactamose inhibitors

Publications (2)

Publication Number Publication Date
GB2052981A GB2052981A (en) 1981-02-04
GB2052981B true GB2052981B (en) 1984-01-11

Family

ID=26272030

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8020953A Expired GB2052981B (en) 1979-07-02 1980-06-26 Penicillanic acid derivatives as -lactamose inhibitors

Country Status (1)

Country Link
GB (1) GB2052981B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486411A (en) * 1980-03-21 1984-12-04 Pfizer Inc. Beta-lactamase inhibiting 6-beta-sulfonyloxypenicillanic acid derivatives

Also Published As

Publication number Publication date
GB2052981A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
GB2081269B (en) Penicillanic acid derivatives
GB2044255B (en) Penicillin derivatives
PT71744A (en) Substituted beta-carbolin-3-carboxylic acid derivatives
ZA80902B (en) N-substituted aziridine-2-carboxylic acid derivatives
AU534754B2 (en) Penicillanic acid derivatives
ZA801016B (en) Mercaptoacyldihydropyrazole carboxylic acid derivatives
GB2117774B (en) Oximinoacetic acid derivatives
GB2047684B (en) 6-substituted penicillanic acids as-lactamase inhibitors
GB2106896B (en) N-substituted aziridine-2-carboxylic acid derivatives
GB2064511B (en) Cephalosporanic acid derivatives
GB2055363B (en) Alkanoic acid derivatives
GB2051046B (en) Penicillanic acid derivatives
GB2053912B (en) Acylaminobenzoic acid derivatives
PH16933A (en) 6-amidino penicillanic acid derivatives including the radical of a beta-lactamase inhibitors
GB2052981B (en) Penicillanic acid derivatives as -lactamose inhibitors
ZA803734B (en) Acylaminobenzoic acid derivatives
GB2125035B (en) 6b-halopenicillanic acid derivatives
GB2051781B (en) Oxoamino acid derivatives
GB2061934B (en) Mercaptoacyldihydropyrazole carboxylic acid derivatives
ZA80905B (en) Penicillin derivatives
SG55984G (en) Penicillanic acid derivatives
DE3064939D1 (en) Sulfonylcarboxylic acid derivatives
ZA80880B (en) 6-beta-substituted penicillanic acids as beta-lactamase inhibitors
ZA806246B (en) Oxayohimbane-carboxylic acid derivatives
IE791028L (en) Penicillanic acid derivative

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee